In colorectal cancer models, AKT3 regulates DNA repair through the IL-13/mTOR signaling pathway, showing differential effects in tumors and normal tissues: reduced AKT3 activation in tumors decreases cell survival, while elevated IL-13 levels in normal tissues enhance AKT3 and mTOR signaling, promoting tissue repair [79]. This evidence concerns the gene IL13 and colorectal cancer.